Introduction.
Blockchain technology is one of the most promising technology trends in the information technology domain. It allows a ledger that is accessible to the parties involved in the transaction and can act as an undeniable universal repository of all transactions between the parties involved. Now an industrial level public blockchain that will revolutionize the textile industry. Everything is on SevenPlus Coin (https://7pluscoin.com/).
What is Seven Plus Coin?
7PLUS COIN is developed to enhance and promote seamless transactions between the Yeh Group of companies and tens of hundreds of future medical establishments worldwide. Such establishments ranges from reputable pharma companies like US WorldMeds, Elorac Inc., Pacira Pharmaceuticals, Inc., Putney/Dechra, Clinipace Worldwide and many others.
7PLUS Coin is an ERC-20 utility token that is built on the Ethereum blockchain. It has a total supply of 200 million tokens, and to be at $0.1 per SV7 coin during private and public sale respectively.
Yeh Group is developing a digital asset called 7PLUS COIN (7SVN COIN), which will serve as a utility token for easy of transaction and tracking of COVID-19 medical textile materials.
The COVID-19 pandemic outbreak reveals the shortcomings in supply chain processes within the healthcare system. 7PLUS COIN is designed to improve the healthcare supply chain management and tracking process of moving COVID-19 medical textile materials like a face mask, hand gloves, etc. In more detail, SevenPlus Coin will be the token implemented for Penn Asia. Penn Asia is a subsidiary of Yeh Group company which responds with blockchain integration in the supply chain process for COVID-19 medical textile materials such as masks, gloves, etc. Yeh Group is developing a digital asset called 7PLUS COIN (SV7 COIN), which will serve as a utility token to facilitate transactions and tracking of COVID-19 medical textile products.
Problems & Solutions
1. Poor healthcare and pharmaceutical supply chain management and tracking
This was a huge problem during the coronavirus pandemic heat. Government agencies found it very difficult to track the volumes and locations of essential supplies. It had a devastating impact on curbing the spread of the virus and protecting the population.
Solution: A blockchain-enabled supply chain allows immutable, transparent, and efficient tracking of medical supply from its production point down to the consumer. Across the supply chain, the blockchain helps to provide information, transparency, proof, accuracy. with such information, supply chain associated risks will be at its minimum for all parties; manufacturers and consumers inclusive.
2. Lack of confidence and Public panic
When it was discovered that the face masks from China to Europe (UK, China, Ireland, etc.) were contaminated, it spread panic among the population. Public panic will do more harm than good as we try to tackle the outbreak of this pandemic.
Solution: A blockchain system that securely tracks and proves the ingredients, production volumes, availability, and quality will significantly improve public confidence in the materials and even drugs. The blockchain system will enable fact-based information sharing. Tracing the origin and endpoints of medical textile material will reduce unnecessary exposure and legal risks.
3. Lack of ease of payment
Traditionally, cross border payments come with high banking fees and time delays due to physical distance. This has really not helped the fight to combat the spread of the coronavirus pandemic. The delay in processing transactions stalls the transportation of medical textile materials on time to places they are needed. Also, large multinational companies find it difficult to keep track of numerous business deals and accounts financially.
Solution: To solve the lack of ease of payment in the supply chain of COVID-19 medical supply kits, one can adopt a digital asset payment system to make it easy for both manufacturers and buyers. A good example of such digital assets is the 7PLUS COIN being created by the Yeh Group of companies.
4. Counterfeit products
The counterfeit drug market is worth a staggering $75 billion annually, including medical textile supplies. On July 24, 2020, INTERPOL reported global seizures of falsified medical products related to Covid-19. The seized items include 34,000 counterfeit and substandard face masks. At a time when standard medical textile supplies are essential, we can’t afford to allow the proliferation of counterfeits into the global market.
Solution: With the decentralized and immutable record features that blockchain offers, we can track every COVID-19 textile medical supplies journey to verify its authenticity or the lack thereof.
YEH GROUP TECHNOLOGY
Yeh Group employs special Drydye waterless technology for the production of its medical textile covid-19 materials. Only 6 manufacturing companies in the world use the DryDye technology. Still, Yeh Group is the only one with a one stop service from yarn spinning, weaving, waterless dyeing, and printing with advanced drydye to avoid water pollution. Aside from the advanced drydye technology, Yeh Group also uses blockchain technology in its supply chain process to enable more transparent and accurate end-to-end tracking of medical textile products. The blockchain protocol allows retailers to verify all covid-19 medical kits’ authenticity coming from the Yeh Group.
TEXTILE MEDICAL SUPPLIES
Medical textile supplies belong to a wide range of materials heavily regulated due to their safety implications. These textile supplies are typically used in the operating theater or hospital wards for staff and patients’ hygiene and safety. They are either washable or disposable. Examples of these medical supplies include surgical gowns, caps, masks, patient drapes, and cover clothes for various sizes. The medical textile supplies used in hospital wards include bedding, clothing, mattresses, covers, and wipes.
7plus Token Sale
The token sale will be in batches and will take place along with some marketing auctions. It will follow a two round token sale offering period to allow investors at various stages contribute to the token sale. The total supply token is 200,000,000, and the price per token is $0.1. The total fund expected to be raised is $20 million. The first sale will be held from February 12, 2021 to February 28, 2021. Those who buy within this period will receive a 25% bonus on their purchase. The second phase of sale will hold between April 1, 2021 to May 31, 2021. People who purchase within the first two weeks of sale will receive 15% bonus. If you buy within 3-4 weeks of sale, you will receive a 10% bonus. Also, those that purchase within 5-8 weeks will receive a bonus of 5%. All sales will end on May 31, 2021. After the soft cap or hard cap is reached, live trading will go public on Bitenium Exchange on June 1, 2021.
Pre Sale
Pre Sale will start Fri, 12 Feb 2021 07:00 (GMT+7)
- % BONUS : ETH
- Total sell: 0.0000 (0.00%) SV7
- Softcap period: 16 Days
- Hardcap period: 60 Days
- Today: 0 SV7
- Total ETH: 0.0000 ETH
- Softcap: 20,000,000 SV7
TOKEN DETAILS
- Name: 7PLUS COIN (SV7)
- Date: Fri, 12 Feb 2021 07:00 (GMT+7)
- Price: 1 SV7 = 0.10 USD
- Homepage: https://7pluscoin.com
- Bonus: 0%
- Softcap: 20,000,000
- Bonus Lockup Hardcap: 180,000,000
- Tech: ERC-20
For more information about this project you can see it below:
- Website: https://7pluscoin.com/
- Facebook: https://www.facebook.com/SV7PlusCoin-103483088392823
- Telegram: https://t.me/English7plus
- Twitter: https://twitter.com/7pluscoin
- Youtube: https://www.youtube.com/channel/UCqqoJ6ai6yLzmcFw_ZxUfJw
- Medium: https://seventhcoin7.medium.com/
Author:
- Username Bitcointalk: gomess1
- Proof of Authentication: https://bitcointalk.org/index.php?topic=5314256.msg56464723#msg56464723